从这三张图来看，创新药大牛市远未结束！

价值投资为王

今天，彭博发了篇深度研报，事关创新药，标题是《中国药企打破全球生物医药行业格局挑战西方创新主导地位》。

研报中附了三张图，对你了解，以及把握后面的创新药行情非常有帮助！

第一张图是美国、欧盟、中国每年获批的创新药数量，其中，美国是100个，中国33个，超过欧盟的28个：

第二张是中国创新药在全球技术授权交易占的占比，从2018年的0%，提升至26%：

第三张图是我国进入研发阶段的抗癌、减肥等新药数量激增至1250多种，远远超过欧盟，逼近美国的1440种：

由此来看，国内创新药才刚刚爆发而已，丰收的果实还在后头！

$百济神州(06160)$ $荣昌生物(09995)$ $信达生物(01801)$ $恒瑞医药(01276)$

分享我的交易策略

交易策略分享，说一说自己在交易中的那些神操作吧，你的idea说不定价值百万！

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

稻草人的风筝
07-14
稻草人的风筝
就是都涨二三十个点了，不太好下手
稻草人的风筝
07-14
稻草人的风筝
能不能回调一下，接我上个车
人生舵手__小琳
07-14
人生舵手__小琳
有没有相关的etf
乐盈
07-16
乐盈
阅读
超越666888
07-15
超越666888
1
Lydia758
07-14
Lydia758
阅

发表看法

6

20

3

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":456523545293112,"tweetId":"456523545293112","gmtCreate":1752492908340,"gmtModify":1752492935772,"author":{"id":21347731130544,"idStr":"21347731130544","authorId":21347731130544,"authorIdStr":"21347731130544","name":"价值投资为王","avatar":"https://static.tigerbbs.com/89ffffc59ff9ac9cb9cb74f596418d44","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.06","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":47569,"starInvestorFlag":false},"themes":[{"themeId":"5f4e0a7185a74ed196abff08008266de","categoryId":"b76d3c59fc044df59779c041b25852a6","name":"分享我的交易策略","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":5f4e0a7185a74ed196abff08008266de}&rnconfig={\"headerBarHidden\": true}","description":"交易策略分享，说一说自己在交易中的那些神操作吧，你的idea说不定价值百万！","image":"https://static.tigerbbs.com/cd8eaff2e99964ab7a80d92cc196fcd3"}],"images":[{"img":"https://static.tigerbbs.com/88717626378c913fa44e238272a7e972","width":"816","height":"490"},{"img":"https://static.tigerbbs.com/84b1b0626decc8da9ddf1f634c04804e","width":"874","height":"426"},{"img":"https://static.tigerbbs.com/329f86d216c74fe0669a3bb3e7849276","width":"786","height":"586"}],"coverImages":[{"img":"https://static.tigerbbs.com/88717626378c913fa44e238272a7e972","width":"816","height":"490"},{"img":"https://static.tigerbbs.com/84b1b0626decc8da9ddf1f634c04804e","width":"874","height":"426"},{"img":"https://static.tigerbbs.com/329f86d216c74fe0669a3bb3e7849276","width":"786","height":"586"}],"title":"从这三张图来看，创新药大牛市远未结束！","html":"<html><head></head><body><p>今天，彭博发了篇深度研报，事关创新药，标题是《中国药企打破全球生物医药行业格局 挑战西方创新主导地位》。</p>\n<p>研报中附了三张图，对你了解，以及把握后面的创新药行情非常有帮助！</p>\n<p>第一张图是美国、欧盟、中国每年获批的创新药数量，其中，美国是100个，中国33个，超过欧盟的28个：</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/88717626378c913fa44e238272a7e972\" tg-width=\"816\" tg-height=\"490\"></p>\n<p>第二张是中国创新药在全球技术授权交易占的占比，从2018年的0%，提升至26%：</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84b1b0626decc8da9ddf1f634c04804e\" tg-width=\"874\" tg-height=\"426\"></p>\n<p>第三张图是我国进入研发阶段的抗癌、减肥等新药数量激增至1250多种，远远超过欧盟，逼近美国的1440种：</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/329f86d216c74fe0669a3bb3e7849276\" tg-width=\"786\" tg-height=\"586\"></p>\n<p>由此来看，国内创新药才刚刚爆发而已，丰收的果实还在后头！</p>\n<p>&nbsp; <a href=\"https://laohu8.com/S/06160\">$百济神州(06160)$</a> <a href=\"https://laohu8.com/S/09995\">$荣昌生物(09995)$</a> <a href=\"https://laohu8.com/S/01801\">$信达生物(01801)$</a> <a href=\"https://laohu8.com/S/01276\">$恒瑞医药(01276)$</a></p></body></html>","htmlText":"<html><head></head><body><p>今天，彭博发了篇深度研报，事关创新药，标题是《中国药企打破全球生物医药行业格局 挑战西方创新主导地位》。</p>\n<p>研报中附了三张图，对你了解，以及把握后面的创新药行情非常有帮助！</p>\n<p>第一张图是美国、欧盟、中国每年获批的创新药数量，其中，美国是100个，中国33个，超过欧盟的28个：</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/88717626378c913fa44e238272a7e972\" tg-width=\"816\" tg-height=\"490\"></p>\n<p>第二张是中国创新药在全球技术授权交易占的占比，从2018年的0%，提升至26%：</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84b1b0626decc8da9ddf1f634c04804e\" tg-width=\"874\" tg-height=\"426\"></p>\n<p>第三张图是我国进入研发阶段的抗癌、减肥等新药数量激增至1250多种，远远超过欧盟，逼近美国的1440种：</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/329f86d216c74fe0669a3bb3e7849276\" tg-width=\"786\" tg-height=\"586\"></p>\n<p>由此来看，国内创新药才刚刚爆发而已，丰收的果实还在后头！</p>\n<p>&nbsp; <a href=\"https://laohu8.com/S/06160\">$百济神州(06160)$</a> <a href=\"https://laohu8.com/S/09995\">$荣昌生物(09995)$</a> <a href=\"https://laohu8.com/S/01801\">$信达生物(01801)$</a> <a href=\"https://laohu8.com/S/01276\">$恒瑞医药(01276)$</a></p></body></html>","text":"今天，彭博发了篇深度研报，事关创新药，标题是《中国药企打破全球生物医药行业格局 挑战西方创新主导地位》。 研报中附了三张图，对你了解，以及把握后面的创新药行情非常有帮助！ 第一张图是美国、欧盟、中国每年获批的创新药数量，其中，美国是100个，中国33个，超过欧盟的28个： 第二张是中国创新药在全球技术授权交易占的占比，从2018年的0%，提升至26%： 第三张图是我国进入研发阶段的抗癌、减肥等新药数量激增至1250多种，远远超过欧盟，逼近美国的1440种： 由此来看，国内创新药才刚刚爆发而已，丰收的果实还在后头！ $百济神州(06160)$ $荣昌生物(09995)$ $信达生物(01801)$ $恒瑞医药(01276)$","highlighted":1,"essential":2,"paper":2,"likeSize":20,"commentSize":6,"repostSize":3,"favoriteSize":0,"link":"https://laohu8.com/post/456523545293112","repostId":0,"isVote":1,"tweetType":1,"viewCount":12434,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09995","01276","06160","01801","ONC","688235","600276","688331"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":524,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":456531557798088,"commentId":"456531557798088","gmtCreate":1752495324365,"gmtModify":1752495683779,"authorId":3548712052573855,"author":{"id":3548712052573855,"idStr":"3548712052573855","authorId":3548712052573855,"name":"稻草人的风筝","avatar":"https://static.tigerbbs.com/bbe8c366cd157bd0ed68672768c0b052","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":456523545293112,"objectIdStr":"456523545293112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"就是都涨二三十个点了，不太好下手","text":"就是都涨二三十个点了，不太好下手","html":"就是都涨二三十个点了，不太好下手","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":456533122245248,"commentId":"456533122245248","gmtCreate":1752495541639,"gmtModify":1752495863789,"authorId":3548712052573855,"author":{"id":3548712052573855,"idStr":"3548712052573855","authorId":3548712052573855,"name":"稻草人的风筝","avatar":"https://static.tigerbbs.com/bbe8c366cd157bd0ed68672768c0b052","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":456523545293112,"objectIdStr":"456523545293112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"能不能回调一下，接我上个车","text":"能不能回调一下，接我上个车","html":"能不能回调一下，接我上个车","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":456540113887872,"commentId":"456540113887872","gmtCreate":1752497248582,"gmtModify":1752497483756,"authorId":4193377325563260,"author":{"id":4193377325563260,"idStr":"4193377325563260","authorId":4193377325563260,"name":"人生舵手__小琳","avatar":"https://static.tigerbbs.com/bca18127aea7146dcdf53d2a249fc2f8","vip":2,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.11","exceedPercentage":"93.72%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.06","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1,"categoryType":2007}]},"repliedAuthorId":0,"objectId":456523545293112,"objectIdStr":"456523545293112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"有没有相关的etf","text":"有没有相关的etf","html":"有没有相关的etf","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":457093023822080,"commentId":"457093023822080","gmtCreate":1752632001596,"gmtModify":1752632303816,"authorId":3584688469231421,"author":{"id":3584688469231421,"idStr":"3584688469231421","authorId":3584688469231421,"name":"乐盈","avatar":"https://static.tigerbbs.com/b3d7f76fe206354675bc6d1a0d47ec9e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":456523545293112,"objectIdStr":"456523545293112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"阅读","text":"阅读","html":"阅读","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":456700484890976,"commentId":"456700484890976","gmtCreate":1752536274379,"gmtModify":1752536543596,"authorId":4120115595748460,"author":{"id":4120115595748460,"idStr":"4120115595748460","authorId":4120115595748460,"name":"超越666888","avatar":"https://static.tigerbbs.com/c7091f180a159a1aca5e96e89241744c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":456523545293112,"objectIdStr":"456523545293112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"1","text":"1","html":"1","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":456582941163616,"commentId":"456582941163616","gmtCreate":1752507700149,"gmtModify":1752507924354,"authorId":3552609846285590,"author":{"id":3552609846285590,"idStr":"3552609846285590","authorId":3552609846285590,"name":"Lydia758","avatar":"https://static.tigerbbs.com/28fe40b632359d10a879ebb9a9eef57b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":456523545293112,"objectIdStr":"456523545293112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"阅","text":"阅","html":"阅","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/456523545293112"}